SHAH JAISIM

CIK 00012421335 companiesLOS ANGELES, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001242133

Recent Transactions

50 trades

Purchase
Scilex Holding Co$SCLX
Common Stock
2024-12-18$0.46/sh+30,000→ 139,333 total
Purchase
Scilex Holding Co$SCLX
Common Stock
2024-10-29$0.99/sh+32,000→ 109,333 total
Purchase
Scilex Holding Co$SCLX
Common Stock
2024-10-16$0.99/sh+30,000→ 77,333 total
Exercise/Conversion
Scilex Holding Co$SCLX
Nonstatutory Stock Option (right to buy)
2024-06-20−14,000→ 7,880,598 total
Exercise/Conversion
Scilex Holding Co$SCLX
Common Stock
2024-06-20$1.73/sh+14,000→ 47,333 total
Exercise/Conversion
Scilex Holding Co$SCLX
Nonstatutory Stock Option (right to buy)
2024-06-14−33,333→ 166,667 total
Exercise/Conversion
Scilex Holding Co$SCLX
Common Stock
2024-06-14$1.41/sh+33,333→ 33,333 total
Purchase
Scilex Holding Co$SCLX
Common Stock
2024-05-17$0.92/sh+56,939→ 155,882 total
Purchase
Scilex Holding Co$SCLX
Common Stock
2024-05-16$0.84/sh+83,061→ 98,943 total
Award
Scilex Holding Co$SCLX
Nonstatutory Stock Option (right to buy)
2023-10-04+200,000→ 200,000 total
Award
Scilex Holding Co$SCLX
Nonstatutory Stock Option (right to buy)
2023-01-17+1,700,000→ 1,700,000 total
Award
Sorrento Therapeutics, Inc.
Stock option (right to buy)
2021-08-30+250,000→ 250,000 total
Award
Sorrento Therapeutics, Inc.
Stock Options
2020-06-15+100,000→ 100,000 total
Award
Sorrento Therapeutics, Inc.
Stock Options
2019-04-19+70,000→ 70,000 total
Award
Sorrento Therapeutics, Inc.
Stock Options
2018-11-26+35,000→ 35,000 total
Award
Sorrento Therapeutics, Inc.
Stock Options
2017-09-15+35,000→ 35,000 total
Award
Sorrento Therapeutics, Inc.
Stock Options
2017-09-15+35,000→ 35,000 total
Purchase
Sorrento Therapeutics, Inc.
Common Stock
2017-06-15$1.79/sh+10,002→ 112,633 total
Purchase
Sorrento Therapeutics, Inc.
Common Stock
2017-02-03$5.15/sh+10,000→ 102,631 total
Award
Sorrento Therapeutics, Inc.
Stock Options
2016-07-11+35,000→ 305,000 total
Purchase
Sorrento Therapeutics, Inc.
Common Stock
2015-08-03$11.50/sh+27,189→ 92,631 total
Award
Sorrento Therapeutics, Inc.
Stock Options
2015-06-04+25,000→ 270,000 total
Award
Sorrento Therapeutics, Inc.
Stock Options
2015-02-24+80,000→ 245,000 total
Award
Sorrento Therapeutics, Inc.
Stock Options
2014-09-18+25,000→ 165,000 total
Purchase
Sorrento Therapeutics, Inc.
Common Stock
2013-11-25$8.65/sh+1,000→ 65,442 total
Purchase
Sorrento Therapeutics, Inc.
Common Stock
2013-11-19$9.00/sh+1,000→ 64,442 total
Award
Sorrento Therapeutics, Inc.
Stock Options
2013-10-29+80,000→ 140,000 total
Exercise/Conversion
PDL BIOPHARMA, INC.
Common Stock
2008-04-28$8.55/sh+469→ 15,343 total
Exercise/Conversion
PDL BIOPHARMA, INC.
Common Stock
2008-04-28$7.83/sh+313→ 16,125 total
Exercise/Conversion
PDL BIOPHARMA, INC.
Stock Option (Right to Buy)
2008-04-28−313→ 0 total
Exercise/Conversion
PDL BIOPHARMA, INC.
Stock Option (Right to Buy)
2008-04-28−469→ 0 total
Sale
PDL BIOPHARMA, INC.
Common Stock
2007-04-23$25.00/sh−8,414→ 13,940 total
Exercise/Conversion
PDL BIOPHARMA, INC.
Employee Stock Option (Right to Buy)
2007-04-23−3,253→ 0 total
Exercise/Conversion
PDL BIOPHARMA, INC.
Employee Stock Option (Right to Buy)
2007-04-23−8,414→ 18,586 total
Exercise/Conversion
PDL BIOPHARMA, INC.
Common Stock
2007-04-23$13.96/sh+3,333→ 17,273 total
Exercise/Conversion
PDL BIOPHARMA, INC.
Common Stock
2007-04-23$12.29/sh+3,253→ 17,193 total
Sale
PDL BIOPHARMA, INC.
Common Stock
2007-04-23$25.00/sh−3,333→ 13,940 total
Exercise/Conversion
PDL BIOPHARMA, INC.
Employee Stock Option (Right to Buy)
2007-04-23−3,333→ 417 total
Sale
PDL BIOPHARMA, INC.
Common Stock
2007-04-23$25.00/sh−3,253→ 13,940 total
Exercise/Conversion
PDL BIOPHARMA, INC.
Common Stock
2007-04-23$15.25/sh+8,414→ 22,354 total
Exercise/Conversion
PDL BIOPHARMA, INC.
Employee Stock Option (Right to buy)
2006-01-09−5,000→ 5,000 total
Sale
PDL BIOPHARMA, INC.
Common Stock
2006-01-09$31.00/sh−5,000→ 1,001 total
Exercise/Conversion
PDL BIOPHARMA, INC.
Common Stock
2006-01-09$12.29/sh+5,000→ 6,001 total
Exercise/Conversion
PDL BIOPHARMA, INC.
Employee Stock Option (Right to buy)
2005-08-03−15,000→ 10,000 total
Exercise/Conversion
PDL BIOPHARMA, INC.
Common Stock
2005-08-03$13.96/sh+1,250→ 2,834 total
Exercise/Conversion
PDL BIOPHARMA, INC.
Common Stock
2005-08-03$12.29/sh+5,000→ 6,584 total
Sale
PDL BIOPHARMA, INC.
Common Stock
2005-08-03$27.00/sh−5,000→ 1,584 total
Sale
PDL BIOPHARMA, INC.
Common Stock
2005-08-03$26.10/sh−10,000→ 1,584 total
Exercise/Conversion
PDL BIOPHARMA, INC.
Employee Stock Option (Right to Buy)
2005-08-03−1,250→ 1,250 total
Exercise/Conversion
PDL BIOPHARMA, INC.
Common Stock
2005-08-03$12.29/sh+10,000→ 11,584 total

SHAH JAISIM

Recent Transactions

Companies

Recent Filings

Address